Abstract
Chronic liver injury can lead to hepatic failure and the only available method of treatment would be liver transplantation. The link between inflammation (TNF-alpha), nuclear factor-kappa B (NF-kB), nitrosative stress (iNOS) and hypoxia-inducible factor-1 alpha (HIF-1 alpha) in thioacetamide (TAA) induced liver fibrosis, and hypertension with and without the incorporation of the anti-inflammatory and antioxidant resveratrol (RES) has not been investigated before. Consequently, we injected rats with either 200 mg/kg TAA for 8 weeks starting at week 2 (model group) or pretreated them before TAA injections with RES (20 mg/kg) for 2 weeks and continued them on RES and TAA until being culled at week 10 (protective group). In the model group, we documented the induction of hepatic fibrosis and upregulation of tumor necrosis factor-alpha (TNF-alpha), NF-kB, inducible nitric oxide synthase (iNOS), HIF-1 alpha and the profibrotic biomarkers alpha-smooth muscle actin (alpha-SMA) and matrix metalloproteinase-9 (MMP-9) that was significantly (p <= 0.0014) ameliorated by RES. RES also significantly (p <= 0.0232) reduced triglycerides (TG), cholesterol (CHOL), very low-density lipoprotein (vLDL-C), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure, and heart rate (HR) induction by TAA. Also, a significant (p < 0.0001) positive correlation between TNF-alpha/NF-kB/iNOS/HIF-1 alpha axis-mediated fibrosis and hypertension and liver injury biomarkers was observed. These findings suggest that in the hepatotoxic compound, TAA is associated with TNF-alpha/NF-kB/iNOS/HIF-1 alpha-mediated fibrosis and hypertension, whilst being inhibited by RES.